SCHEMBL15599340

SCHEMBL15599340

Brc1cc2cc[nH]c2nc1C1CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 1/20 0.36
▸ AHR P35869 2/20 0.35
▸ JAK2 O60674 8/20 0.33
▸ JAK1 P23458 8/20 0.33
▸ JAK3 P52333 8/20 0.33
▸ TYK2 P29597 7/20 0.33
▸ ALOX5AP P20292 3/20 0.33
▸ FEN1 P39748 3/20 0.33
▸ AXL P30530 1/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ PRKCI P41743 1/20 0.33
▸ IGF1R P08069 1/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ RIPK1 Q13546 1/20 0.32
▸ CYP2A6 P11509 1/20 0.32
▸ NR4A2 P43354 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25613031 0.76 JAK2 (0.36) JAK2JAK1JAK3TYK2ALOX5AP
SCHEMBL18129582 0.71 CSNK2A1 (0.40) CSNK2A1AHRAXLCDK8PRKCI
SCHEMBL1565089 0.71 AXL (0.41) CSNK2A1AHRAXLCDK8PRKCI
SCHEMBL1565481 0.71 CSNK2A1 (0.48) CSNK2A1AHRAXLCDK8PRKCI
SCHEMBL4242878 0.71 ALDH1A1 (0.44) CSNK2A1AHRAXLCDK8PRKCI
SCHEMBL14630025 0.67 AXL (0.39) AHRJAK2JAK1JAK3TYK2
SCHEMBL25346767 0.67 BRD4 (0.42) CSNK2A1ALOX5APFEN1AXLCDK8
SCHEMBL21639429 0.67 RIPK1 (0.43) CSNK2A1AHRAXLCDK8PRKCI
SCHEMBL299377 0.67 TNKS (0.53) CSNK2A1JAK2JAK3ALOX5APFEN1
SCHEMBL20553146 0.66 ALDH1A1 (0.39) CSNK2A1JAK2AXLCDK8PRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9353107-B2 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2016-05-31 — — US disclosed
US-9353107-B2 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2016-05-31 — — US disclosed
US-9353107-B2 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2016-05-31 — — US disclosed
US-20150336949-A1 3-(Pyrazolyl)-1H-Pyrrolo[2,3-b]Pyridine Derivatives as Kinase Inhibitors Um Pharmauji Sdn. Bhd. (MY) 2015-11-26 — — US disclosed
US-20150336949-A1 3-(Pyrazolyl)-1H-Pyrrolo[2,3-b]Pyridine Derivatives as Kinase Inhibitors Um Pharmauji Sdn. Bhd. (MY) 2015-11-26 — — US disclosed
US-20150336949-A1 3-(Pyrazolyl)-1H-Pyrrolo[2,3-b]Pyridine Derivatives as Kinase Inhibitors Um Pharmauji Sdn. Bhd. (MY) 2015-11-26 — — US disclosed
WO-2014006554-A1 3-(PYRAZOLYL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2014-01-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336949-A1 3-(Pyrazolyl)-1H-Pyrrolo[2,3-b]Pyridine Derivatives as Kinase Inhibitors MAP3K3, MAP3K1, MAP3K6 CSNK2A1 89/4885AHR 3352/4885JAK2 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback